Advertisement

HIV Care Today


Canadian Study Examines Why Some Women Fall Out of the HIV Care Cascade
By Sean R. Hosein
October 3, 2018

In a study of more than 1,400 women living with HIV, nearly 30% did not achieve viral suppression and some groups of women had greater challenges with adherence and staying in care.

Read more …


Doravirine Sets a New Standard for NNRTIs -- but What Role in HIV Treatment Today?
By Paul E. Sax, M.D.
September 10, 2018

The HIV drug class called "non-nucleoside reverse transcriptase inhibitors," or NNRTIs, must have something of an inferiority complex.

Read more …


California: A Health Care Laboratory With Mixed Results
By Anna Gorman
September 7, 2018

California's expansion of Medicaid under the Affordable Care Act enabled many low-income HIV patients to get health insurance previously denied to them. Still, those with mental health needs, who had been receiving coordinated care through a separate federal program, suddenly faced gaps in treatment, payment disputes and doctors who had little understanding of life with HIV.

Read more …


To Understand Challenges Black Men With HIV Face on Re-Entry From Prisons, an Intersectional Approach Is Needed, Study Shows
By Stephen Hicks
August 28, 2018

There are multiple reasons why re-entry into communities from prison for black men with HIV is a difficult proposition, according to a recent study published in Social Science and Medicine. The researchers show that the intersectionality framework is applicable to understanding the challenges these men face after serving time in prison.

Read more …


Why Caring for People With HIV Is Still Great
By Paul E. Sax, M.D.
August 6, 2018

Earlier this year, I wrote a piece about friends and colleagues of mine who have left HIV clinical practice. Something about it touched a nerve. It's one of the most commented-on pieces in the history of this blog.

Read more …


Really Rapid Review: International AIDS Conference 2018, Amsterdam
By Paul E. Sax, M.D.
July 31, 2018

The International AIDS Conference -- or "AIDS 2018" -- returned to Amsterdam for the first time since 1992.

Read more …


FDA Approves First PI-Based Single-Tablet Treatment for HIV -- How Will It Be Used?
By Paul E. Sax, M.D.
July 25, 2018

The latest HIV drug approval from the FDA came this past week with the release of a single-tablet treatment containing the following drugs:

  1. Darunavir (DRV) 800 mg
  2. Cobicistat (c) 150 mg
  3. Emtricitabine (FTC) 200 mg
  4. Tenofovir alafenamide (TAF) 10 mg

Read more …


To Breastfeed or Not to Breastfeed While Living With HIV? Data Needed!
By Barbara Jungwirth
July 18, 2018

After the United States' recent opposition to a World Health Organization (WHO) resolution promoting breastfeeding, U.S. president Donald Trump said that infant formula was needed especially for women in resource-poor situations. However, that's exactly when breastfeeding is safer than formula, Michele Barry, M.D., FACP, of the Stanford School of Medicine, argued in a New York Times article on this controversy.

Read more …


Lung Cancer Risk and Screening With HIV -- and an Intriguing New Treatment Opportunity
By Mark Mascolini
July 2, 2018

Highly regarded for his contributions to cancer research in people with HIV, Dr. Sigel is Assistant Professor of Medicine in the Division of General Internal Medicine and the Division of Infectious Diseases at the Icahn School of Medicine at Mount Sinai in New York City. With a focus on two non-AIDS-defining malignancies -- lung cancer and anal cancer -- Dr. Sigel has led numerous innovative studies on these conditions and others in people with HIV. His work addresses unique aspects of HIV-related malignancy, including risk, prevention, treatment, and prognosis. He cochairs the Cancer Core of the Veterans Aging Cohort Study, a large longitudinal comparison of HIV-positive and -negative veterans with equivalent access to care and a high lung cancer burden. With an MD and a Masters in Public Health from the University of North Carolina and a PhD from Mount Sinai, Dr. Sigel devotes time to the primary care of people with HIV infection and hepatitis C infection. His many speaking invitations include talks at Yale University, the University of Massachusetts, and the University of North Carolina.

Read more …


Today Is the Day: A Call to Action for Providers During LGBTQ Pride Month
By Jessica Halem, M.B.A.
June 12, 2018

By the looks of my Instagram feed and this month's events calendar, everything is going great for LGBTQ people. The bright colors and loud music are a good balm to ward off the extra stress we carry with us as sexual and gender minorities; lesbians; gay men; and bisexual, transgender, non-binary, and intersex people. What bad day couldn't be helped by a little glitter?

Read more …

 1  |  2  |  3  |  …  |  24  |  Next > 

Get email notifications every time HIV Care Today is updated.



This article was provided by TheBodyPRO.
 

Advertisement

The content on this page is free of advertiser influence and was produced by our editorial team. See our content and advertising policies.